{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:04:34Z","timestamp":1789596274009,"version":"build-2803163510"},"reference-count":100,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:p>Diabetes affects an estimated 828 million people worldwide; prevalence is growing rapidly in low- and middle-income countries (LMICs), with major health and development consequences. Diabetes-related complications and mortality rates have declined across several high-income countries (HICs), largely through structured chronic disease care, sustained implementation of quality improvement strategies, and active risk factor control. However, rates of diabetes complications and mortality have been rising in LMICs. Along with evidence there are tools (e.g., teams, task shifting, data systems, decision-support mechanisms, etc.) for translating the gains in HICs to LMICs. Lessons from global collaborations in vaccines and antiretroviral therapy, especially in innovative ways of leveraging infrastructure, and lowering costs of therapeutics, can be applied to diabetes prevention and control. Furthermore, the following are several transformational opportunities that, if leveraged, can propel global diabetes prevention and control: 1) increasing recognition of diabetes heterogeneity and the differences in the frequency of diabetes subtypes in LMICs; 2) growth in therapeutics and technologies (e.g., mobile health [mHealth], telemedicine, artificial intelligence), which can help overcome infrastructural constraints and stimulate innovative models of prevention care; and 3) sustained economic growth across several LMICs, which offers possibilities of investment in health and data infrastructure and in research and development. Importantly, while \u223c80% of the diabetes burden is in LMICs, &amp;gt;95% of diabetes-related research occurs in populations residing in HICs. This burden-knowledge gap is a major source of health inequity that must be strategically addressed to effectively prevent and control diabetes globally.<\/jats:p>","DOI":"10.2337\/dci25-0116","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:01:56Z","timestamp":1784574116000},"page":"1297-1307","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Global Diabetes: Rapidly Changing Landscape and a Rising Tide of Opportunities: The 2025 Distinguished International Service in the Cause of Diabetes Award Lecture"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8621-5405","authenticated-orcid":false,"given":"K.M. Venkat","family":"Narayan","sequence":"first","affiliation":[{"name":"Emory Global Diabetes Research Center, Woodruff Health Sciences Center and Emory University , Atlanta, GA"},{"name":"Hubert Department of Global Health, Rollins School of Public Health, Emory University , Atlanta, GA"},{"name":"Department of Endocrinology, School of Medicine, Emory University , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"2026072015015235600_B1","doi-asserted-by":"crossref","first-page":"e13366","DOI":"10.1111\/obr.13366","article-title":"The nutrition transition to a stage of high obesity and noncommunicable disease prevalence dominated by ultra-processed foods is not inevitable","volume":"23","author":"Popkin","year":"2022","journal-title":"Obes Rev"},{"key":"2026072015015235600_B2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(23)01296-5","article-title":"Diabetes: a defining disease of the 21st century","volume":"401","author":"The Lancet","year":"2023","journal-title":"Lancet"},{"key":"2026072015015235600_B3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2024","journal-title":"Lancet"},{"key":"2026072015015235600_B4","unstructured":"International Diabetes Federation.\n          \n          IDF Diabetes Atlas. 8th Edition. Brussels, Belgium, International Diabetes Federation, 2017. Accessed 15 December 2025. Available from https:\/\/www.diabetesatlas.org"},{"key":"2026072015015235600_B5","article-title":"Global Health Estimates: Life Expectancy and Leading Causes of Death and Disability","author":"World Health Organization."},{"key":"2026072015015235600_B6","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1038\/s41591-024-03123-2","article-title":"The burden of diabetes-associated multiple long-term conditions on years of life spent and lost","volume":"30","author":"Gregg","year":"2024","journal-title":"Nat Med"},{"key":"2026072015015235600_B7","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990-2010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"2026072015015235600_B8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2337\/dci24-0022","article-title":"Trends and inequalities in diabetes-related complications among U.S. adults, 2000\u20132020","volume":"48","author":"Saelee","year":"2025","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","volume":"10","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"2026072015015235600_B11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"key":"2026072015015235600_B12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B13","doi-asserted-by":"crossref","first-page":"dyad182","DOI":"10.1093\/ije\/dyad182","article-title":"Diabetes mortality: trends and multi-country analysis of the Americas from 2000 to 2019","volume":"53","author":"Antini","year":"2024","journal-title":"Int J Epidemiol"},{"key":"2026072015015235600_B14","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.2337\/dc20-0886","article-title":"Contrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: cohort study data from 143,567 individuals in 21 countries in the PURE study","volume":"43","author":"Anjana","year":"2020","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B15","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"2026072015015235600_B16","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2214-109X(25)00393-6","article-title":"Attainment of global diabetes targets in 2021: a pooled analysis of individual-level data from national surveys in 100 low-income, middle-income, and high-income countries","volume":"14","author":"Global Health and Population Project on Access to Care for Cardiometabolic Diseases Collaborators","year":"2026","journal-title":"Lancet Glob Health"},{"key":"2026072015015235600_B17","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/dc16-0205","article-title":"Type 2 diabetes: why we are winning the battle but losing the war? 2015 Kelly West Award Lecture","volume":"39","author":"Narayan","year":"2016","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B18","doi-asserted-by":"crossref","first-page":"e1543","DOI":"10.1016\/S2214-109X(23)00502-8","article-title":"Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older","volume":"13","author":"Sekher","year":"2025","journal-title":"Lancet Glob Health"},{"key":"2026072015015235600_B19","doi-asserted-by":"crossref","first-page":"e2004","DOI":"10.1002\/hsr2.2004","article-title":"Diabetes mellitus, the fastest growing global public health concern: early detection should be focused","volume":"7","author":"Hossain","year":"2024","journal-title":"Health Sci Rep"},{"key":"2026072015015235600_B20","doi-asserted-by":"crossref","first-page":"101650","DOI":"10.1016\/j.eclinm.2022.101650","article-title":"The effectiveness of lifestyle interventions on type 2 diabetes and gestational diabetes incidence and cardiometabolic outcomes: a systematic review and meta-analysis of evidence from low- and middle-income countries","volume":"53","author":"Sagastume","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026072015015235600_B21","doi-asserted-by":"crossref","first-page":"e63975","DOI":"10.2196\/63975","article-title":"Effectiveness of different intervention modes in lifestyle intervention for the prevention of type 2 diabetes and the reversion to normoglycemia in adults with prediabetes: systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Wang","year":"2025","journal-title":"J Med Internet Res"},{"key":"2026072015015235600_B22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","article-title":"Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials","volume":"177","author":"Haw","year":"2017","journal-title":"JAMA Intern Med"},{"key":"2026072015015235600_B23","first-page":"209","volume-title":"Disease Control Priorities: Cardiovascular, Respiratory, and Related Disorders.","author":"Ali","year":"2017"},{"key":"2026072015015235600_B24","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in U.S. diabetes care, 1999\u20132010","volume":"368","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"key":"2026072015015235600_B25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.7326\/0003-4819-144-7-200604040-00005","article-title":"Improvements in diabetes processes of care and intermediate outcomes: United States, 1988\u20132002","volume":"144","author":"Saaddine","year":"2006","journal-title":"Ann Intern Med"},{"key":"2026072015015235600_B26","doi-asserted-by":"crossref","first-page":"e79638","DOI":"10.1371\/journal.pone.0079638","article-title":"Development and validation of a clinical and computerised decision support system for management of hypertension (DSS-HTN) at a primary health care (PHC) setting","volume":"8","author":"Anchala","year":"2013","journal-title":"PLoS One"},{"key":"2026072015015235600_B27","doi-asserted-by":"crossref","first-page":"e001213","DOI":"10.1161\/JAHA.114.001213","article-title":"Evaluation of effectiveness and cost-effectiveness of a clinical decision support system in managing hypertension in resource constrained primary health care settings: results from a cluster randomized trial","volume":"4","author":"Anchala","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"2026072015015235600_B28","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.115.015373","article-title":"A cluster-randomized, controlled trial of a simplified multifaceted management program for individuals at high cardiovascular risk (SimCard Trial) in rural Tibet, China, and Haryana, India","volume":"132","author":"Tian","year":"2015","journal-title":"Circulation"},{"key":"2026072015015235600_B29","doi-asserted-by":"crossref","first-page":"e004343","DOI":"10.1161\/JAHA.116.004343","article-title":"Development of a smartphone-enabled hypertension and diabetes mellitus management package to facilitate evidence-based care delivery in primary healthcare facilities in India: the mPower Heart Project","volume":"5","author":"Ajay","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026072015015235600_B30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/CIRCULATIONAHA.118.038192","article-title":"Effectiveness of an mHealth-based electronic decision support system for integrated management of chronic conditions in primary care: the mWellcare cluster-randomized controlled trial","volume":"139","author":"Prabhakaran","year":"2019","journal-title":"Circulation"},{"key":"2026072015015235600_B31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.gheart.2019.06.002","article-title":"Strategies for stakeholder engagement and uptake of new intervention: experience from state-wide implementation of mHealth technology for NCD care in Tripura, India","volume":"14","author":"Jindal","year":"2019","journal-title":"Glob Heart"},{"key":"2026072015015235600_B32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1186\/s12913-020-05851-w","article-title":"The Integrated Tracking, Referral, and Electronic Decision Support, and Care Coordination (I-TREC) program: scalable strategies for the management of hypertension and diabetes within the government healthcare system of India","volume":"20","author":"Patel","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2026072015015235600_B33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12884-022-05249-y","article-title":"A cluster randomized controlled trial of an electronic decision-support system to enhance antenatal care services in pregnancy at primary healthcare level in Telangana, India: trial protocol","volume":"23","author":"Mohan","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"2026072015015235600_B34","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B35","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s43058-023-00516-1","article-title":"Adapting and scaling a proven diabetes prevention program across 11 worksites in India: the INDIA-WORKS trial","volume":"4","author":"Weber","year":"2023","journal-title":"Implement Sci Commun"},{"key":"2026072015015235600_B36","doi-asserted-by":"crossref","first-page":"e1004335","DOI":"10.1371\/journal.pmed.1004335","article-title":"Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: post hoc analyses of the CARRS randomized clinical trial","volume":"21","author":"Ali","year":"2024","journal-title":"PLoS Med"},{"key":"2026072015015235600_B37","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/M15-2807","article-title":"Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial","volume":"165","author":"Ali","year":"2016","journal-title":"Ann Intern Med"},{"key":"2026072015015235600_B38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/jama.2020.11747","article-title":"Effect of a collaborative care model on depressive symptoms and glycated hemoglobin, blood pressure, and serum cholesterol among patients with depression and diabetes in India: the INDEPENDENT randomized clinical trial","volume":"324","author":"Ali","year":"2020","journal-title":"JAMA"},{"key":"2026072015015235600_B39","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1186\/s12913-022-08025-y","article-title":"Improving care for hypertension and diabetes in india by addition of clinical decision support system and task shifting in the national NCD program: I-TREC model of care","volume":"22","author":"Jindal","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026072015015235600_B40","article-title":"Operational Guidelines: National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD) (2023\u20132030)","author":"Ministry of Health & Family Welfare","year":"2023"},{"key":"2026072015015235600_B41","volume-title":"Disease Control Priorities in Developing Countries.","author":"Narayan","year":"2006","edition":"2nd"},{"key":"2026072015015235600_B42","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"2026072015015235600_B43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/clinem\/dgae844","article-title":"A research roadmap to address the heterogeneity of diabetes and advance precision medicine","volume":"110","author":"Franks","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072015015235600_B44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"2026072015015235600_B45","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.2337\/dc25-S007","article-title":"7. Diabetes technology: Standards of Care in Diabetes\u20142025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B46","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41591-023-02502-5","article-title":"Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine","volume":"29","author":"Tobias","year":"2023","journal-title":"Nat Med"},{"key":"2026072015015235600_B47","doi-asserted-by":"crossref","first-page":"e3192","DOI":"10.1002\/dmrr.3192","article-title":"Tale of two Indians: heterogeneity in type 2 diabetes pathophysiology","volume":"35","author":"Staimez","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"2026072015015235600_B48","doi-asserted-by":"crossref","first-page":"e001988","DOI":"10.1136\/bmjdrc-2020-001988","article-title":"Incidence of diabetes in South Asian young adults compared to Pima Indians","volume":"9","author":"Narayan","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072015015235600_B49","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2213-8587(25)00256-6","article-title":"Type 2 diabetes subtypes classification: a global reckoning with heterogeneity","volume":"13","author":"Jagannathan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B50","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s43856-023-00360-3","article-title":"Precision subclassification of type 2 diabetes: a systematic review","volume":"3","author":"Misra","year":"2023","journal-title":"Commun Med (Lond)"},{"key":"2026072015015235600_B52","doi-asserted-by":"crossref","first-page":"e2106","DOI":"10.1210\/clinem\/dgaa962","article-title":"Association of diabetes subgroups with race\/ethnicity, risk factor burden and complications: the MASALA and MESA studies","volume":"106","author":"Bancks","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072015015235600_B53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-021-05543-y","article-title":"Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver","volume":"65","author":"Prasad","year":"2022","journal-title":"Diabetologia"},{"key":"2026072015015235600_B54","doi-asserted-by":"crossref","first-page":"e001506","DOI":"10.1136\/bmjdrc-2020-001506","article-title":"Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study","volume":"8","author":"Anjana","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072015015235600_B55","doi-asserted-by":"crossref","first-page":"1426-P","DOI":"10.2337\/db24-1426-P","article-title":"1426-P: type 2 diabetes phenotypes and their association with mortality in South Asians\u2014findings from the Center for Cardiometabolic Risk Reduction in South Asia (CARRS) study","volume":"73","author":"Tiwari","year":"2024","journal-title":"Diabetes"},{"key":"2026072015015235600_B56","doi-asserted-by":"crossref","first-page":"112374","DOI":"10.1016\/j.diabres.2025.112374","article-title":"Novel data-driven pathophysiological phenotypes among women with prediabetes in an Indian population","volume":"226","author":"Mathews","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026072015015235600_B57","doi-asserted-by":"crossref","first-page":"e005504","DOI":"10.1136\/bmjdrc-2025-005504","article-title":"African immigrants with type 2 diabetes present with three physiologic subtypes: implications for screening, diagnosis and treatment","volume":"14","author":"Huefner","year":"2026","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072015015235600_B58","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.pcd.2022.09.007","article-title":"Ethnic differences between Asians and non-Asians in clustering-based phenotype classification of adult-onset diabetes mellitus: a systematic narrative review","volume":"16","author":"Varghese","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"2026072015015235600_B59","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S2213-8587(23)00164-X","article-title":"The case for precision medicine in the prevention, diagnosis, and treatment of cardiometabolic diseases in low-income and middle-income countries","volume":"11","author":"Misra","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B60","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s00125-024-06309-y","article-title":"Type 2 diabetes pathway-specific polygenic risk scores elucidate heterogeneity in clinical presentation, disease progression and diabetic complications in 18,217 Chinese individuals with type 2 diabetes","volume":"68","author":"Yu","year":"2025","journal-title":"Diabetologia"},{"key":"2026072015015235600_B61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00125-022-05671-z","article-title":"Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function","volume":"65","author":"Siddiqui","year":"2022","journal-title":"Diabetologia"},{"key":"2026072015015235600_B62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41746-024-01034-7","article-title":"AI-based diabetes care: risk prediction models and implementation concerns","volume":"7","author":"Wang","year":"2024","journal-title":"NPJ Digit Med"},{"key":"2026072015015235600_B63","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","article-title":"Artificial intelligence for diabetes care: current and future prospects","volume":"12","author":"Sheng","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B64","doi-asserted-by":"crossref","first-page":"1517930","DOI":"10.1080\/16549716.2018.1517930","article-title":"Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings","volume":"11","author":"Jindal","year":"2018","journal-title":"Glob Health Action"},{"key":"2026072015015235600_B65","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes.","year":"2026","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B66","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s44321-025-00191-w","article-title":"Exposomics: a review of methodologies, applications, and future directions in molecular medicine","volume":"17","author":"Wan","year":"2025","journal-title":"EMBO Mol Med"},{"key":"2026072015015235600_B67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3390\/bios12121131","article-title":"Wearable sensor-based monitoring of environmental exposures and the associated health effects: a review","volume":"12","author":"Lin","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"2026072015015235600_B68","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.2337\/dc26-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: Standards of Care in Diabetes\u20142026","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes","year":"2026","journal-title":"Diabetes Care"},{"key":"2026072015015235600_B69","doi-asserted-by":"crossref","first-page":"e004431","DOI":"10.1136\/bmjdrc-2024-004431","article-title":"Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA","volume":"12","author":"King","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072015015235600_B70","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/CIRCULATIONAHA.119.041730","article-title":"Use of guideline-recommended risk reduction strategies among patients with diabetes and atherosclerotic cardiovascular disease","volume":"140","author":"Arnold","year":"2019","journal-title":"Circulation"},{"key":"2026072015015235600_B71","doi-asserted-by":"crossref","first-page":"2043-LB","DOI":"10.2337\/db25-2043-LB","article-title":"2043-LB: universal access to GLP1-RAs could reduce global obesity prevalence by 20% and save 28 million lives over five years\u2014a microsimulation study","volume":"74","author":"Staton","year":"2025","journal-title":"Diabetes"},{"key":"2026072015015235600_B72","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"2026072015015235600_B73","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/M14-0019","article-title":"A cascade of care for diabetes in the United States: visualizing the gaps","volume":"161","author":"Ali","year":"2014","journal-title":"Ann Intern Med"},{"key":"2026072015015235600_B74","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S2213-8587(23)00129-8","article-title":"Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward","volume":"11","author":"Hassan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B75","doi-asserted-by":"crossref","first-page":"e243474","DOI":"10.1001\/jamanetworkopen.2024.3474","article-title":"Estimated sustainable cost-based prices for diabetes medicines","volume":"7","author":"Barber","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026072015015235600_B76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S2213-8587(24)00376-0","article-title":"The era of GLP-1 receptor agonists: costs versus benefits","volume":"13","author":"The Lancet Diabetes Endocrinology","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B77","article-title":"Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022-2030","author":"Global HIV, Hepatitis and STI Programmes.","year":"2022"},{"key":"2026072015015235600_B78","unstructured":"PEPFAR.\n          \n          \n            PEPFAR\u2019s Five-Year Strategy: Fulfilling America\u2019s Promise to End the HIV\/AIDS Pandemic by 2030\n          , 2022. Accessed 27 January 2026. Available from https:\/\/www.state.gov\/wp-content\/uploads\/2022\/11\/PEPFARs-5-Year-Strategy_WAD2022_FINAL_COMPLIANT_3.0.pdf"},{"key":"2026072015015235600_B79","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S2213-8587(23)00359-5","article-title":"Enhancing global access to diabetes medicines: policy lessons from the HIV response","volume":"12","author":"Teufel","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B80","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1590\/0102-311XPE010514","article-title":"Assuring access to quality antiretroviral medicines: the WHO Prequalification of Medicines Program and access to HIV treatment","volume":"30","author":"t\u2019Hoen","year":"2014","journal-title":"Cad Saude Publica"},{"key":"2026072015015235600_B81","article-title":"Accelerating Access Initiative: Widening Access to Care and Support for People Living with HIV\/AIDS: Progress Report, June 2002","author":"World Health Organization.","year":"2002"},{"key":"2026072015015235600_B82","doi-asserted-by":"crossref","DOI":"10.5089\/9798229023948.081","article-title":"World Economic Outlook, October 2025: Global Economy in Flux, Prospects Remain Dim","author":"International Monetary Fund.","year":"2025"},{"key":"2026072015015235600_B83","doi-asserted-by":"crossref","DOI":"10.1596\/978-1-4648-2193-6","article-title":"Global Economic Prospects, June 2025","author":"World Bank Group.","year":"2025"},{"key":"2026072015015235600_B84","doi-asserted-by":"crossref","first-page":"e1098","DOI":"10.1016\/S2468-2667(24)00251-2","article-title":"Diabetes in China part 2: prevention, challenges, and progress","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"key":"2026072015015235600_B85","doi-asserted-by":"crossref","first-page":"e1706","DOI":"10.1016\/S2214-109X(24)00118-9","article-title":"Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared?","volume":"12","author":"Ahmed","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026072015015235600_B86","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1038\/s41591-025-03923-0","article-title":"Global distribution of research efforts, disease burden, and impact of US public funding withdrawal","volume":"31","author":"Schmallenbach","year":"2025","journal-title":"Nat Med"},{"key":"2026072015015235600_B87","volume-title":"IDF Diabetes Atlas. 10th Edition.","author":"International Diabetes Federation","year":"2021"},{"key":"2026072015015235600_B88","doi-asserted-by":"crossref","first-page":"e0234962","DOI":"10.1371\/journal.pone.0234962","article-title":"Diversity and inclusion for the All of Us research program: a scoping review","volume":"15","author":"Mapes","year":"2020","journal-title":"PLoS One"},{"key":"2026072015015235600_B89","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41591-019-0492-5","article-title":"Genome-wide association study of peripheral artery disease in the Million Veteran Program","volume":"25","author":"Klarin","year":"2019","journal-title":"Nat Med"},{"key":"2026072015015235600_B90","article-title":"Asians in the U.S. (Asian Americans in the U.S.). Analysis of 2023 American Community Survey (ACS) Tabulations","author":"Pew Research Center.","year":"2025"},{"key":"2026072015015235600_B91","doi-asserted-by":"crossref","first-page":"e197432","DOI":"10.1001\/jamanetworkopen.2019.7432","article-title":"Trends in clinical research including Asian American, Native Hawaiian, and Pacific Islander participants funded by the US National Institutes of Health, 1992 to 2018","volume":"2","author":"\u00d0o\u00e0n","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026072015015235600_B92","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00125-025-06513-4","article-title":"Ethnic diversity in precision medicine: a reality or an aspiration?","volume":"68","author":"Misra","year":"2025","journal-title":"Diabetologia"},{"key":"2026072015015235600_B93","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.annepidem.2025.06.021","article-title":"A large language model analysis of global inequities in precision medicine research on diabetes","volume":"109","author":"Soniwala","year":"2025","journal-title":"Ann Epidemiol"},{"key":"2026072015015235600_B94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12961-024-01187-7","article-title":"If health organisations and staff engage in research, does healthcare improve? Strengthening the evidence base through systematic reviews","volume":"22","author":"Boaz","year":"2024","journal-title":"Health Res Policy Syst"},{"key":"2026072015015235600_B95","volume-title":"Innovation and Public Policy.","author":"Austan","year":"2022"},{"key":"2026072015015235600_B96","article-title":"Research and Development Expenditure (% of GDP)","author":"World Bank Group.","year":"2025"},{"key":"2026072015015235600_B97","doi-asserted-by":"crossref","first-page":"e0118253","DOI":"10.1371\/journal.pone.0118253","article-title":"Research activity and the association with mortality","volume":"10","author":"Ozdemir","year":"2015","journal-title":"PLoS One"},{"key":"2026072015015235600_B98","first-page":"543","article-title":"Copenhagen Declaration: a transformative vision for global diabetes","volume":"13","author":"Narayan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072015015235600_B99","article-title":"Copenhagen Declaration: A blueprint for Diabetes Care and Research in an Interconnected World","author":"Beyh","year":"2024"},{"key":"2026072015015235600_B100","unstructured":"Our World in Data\n          . Death rate from diabetes: IHME. Our World in Data, 2026. Accessed 10 February 2026. Available from https:\/\/ourworldindata.org\/grapher\/death-rate-from-diabetes-gbd"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1297\/889258\/dci250116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1297\/889258\/dci250116.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:02:13Z","timestamp":1784574133000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/8\/1297\/172218\/Global-Diabetes-Rapidly-Changing-Landscape-and-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":100,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,20]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dci25-0116","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]}}}